Identification of Connective Tissue Growth Factor as a Target of WT1 Transcriptional Regulation
Open Access
- 1 December 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (49) , 38139-38150
- https://doi.org/10.1074/jbc.m004901200
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- WT1—more than a transcription factor?Trends in Biochemical Sciences, 1998
- Expression of connective tissue growth factor in human renal fibrosisKidney International, 1998
- Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domainOncogene, 1997
- Effects of Denys−Drash Syndrome Point Mutations on the DNA Binding Activity of the Wilms' Tumor Suppressor Protein WT1Biochemistry, 1996
- DNA binding capacity of the WT1 protein is abolished by Denys—Drash syndrome WT1 point mutationsHuman Molecular Genetics, 1995
- Structure, chromosomal localization, and expression of 12 genes of the MAGE familyImmunogenetics, 1994
- WT-1 is required for early kidney developmentCell, 1993
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10.The Journal of cell biology, 1991
- Wilms Tumor Locus on 11p13 Defined by Multiple CpG Island-Associated TranscriptsScience, 1990